Atrás
Precio Bioxytran Inc (BIXT)
Gráfico del Precio de Acciones BIXT
BIXT Ganando
Bioxytran Inc
$0.04
-0.7%
$0
Al cierre: Feb 12, 16:00:00 GMT-5
$0.04
0%
$0
Mercado Posterior: Feb 12, 20:00:00 GMT-5
Sin datos aúnEarnings FAQ
¿Cómo se comparó el EPS reciente de BIXT con las expectativas?
¿Cómo fue el desempeño de los ingresos de Bioxytran Inc BIXT en el último trimestre?
¿Cuál es la estimación de ingresos para Bioxytran Inc?
¿Cuál es la puntuación de calidad de ganancias de Bioxytran Inc?
¿Cuándo informa Bioxytran Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Bioxytran Inc?
¿Superó Bioxytran Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.0493
Precio de apertura
$0.049
Rango del día
$0.0476 - $0.0493
Rango de 52 semanas
$0.0342 - $0.2283
Volumen
8.1K
Volumen promedio
175.6K
EPS (TTM)
-0.02
Rendimiento de dividendos
--
Cap. de mercado
$4.8M
¿Qué es BIXT?
BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. The company is headquartered in Needham, Massachusetts. The company went IPO on 2010-01-05. The firm is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The firm's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with intended applications, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.